scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1113184522 |
P356 | DOI | 10.1186/S13046-019-1142-Y |
P932 | PMC publication ID | 6449973 |
P698 | PubMed publication ID | 30947731 |
P2093 | author name string | Qin Wang | |
Liang Tao | |||
Xiyan Wang | |||
Hui Ge | |||
Yunquan Guo | |||
Yuke Xiang | |||
Yile Fu | |||
P2860 | cites work | Gap junction gene and protein families: Connexins, innexins, and pannexins. | Q50970758 |
Gap junction as an intercellular glue: Emerging roles in cancer EMT and metastasis. | Q51216580 | ||
Cytoplasmic accumulation of connexin32 protein enhances motility and metastatic ability of human hepatoma cells in vitro and in vivo. | Q53335533 | ||
2-aminoethoxydiphenyl borate directly inhibits channels composed of connexin26 and/or connexin32. | Q53589060 | ||
Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer. | Q54548291 | ||
Implications and challenges of connexin connections to cancer. | Q55052930 | ||
Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition | Q59794754 | ||
Modifications in connexin expression in liver development and cancer | Q38040852 | ||
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma | Q38052472 | ||
Connexin a check-point component of cell apoptosis in normal and physiopathological conditions | Q38168634 | ||
The cytoplasmic translocation of Cx32 mediates cisplatin resistance in ovarian cancer cells | Q38707550 | ||
Gap junction structure: unraveled, but not fully revealed | Q39321400 | ||
Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin. | Q39437541 | ||
Cytoplasmic accumulation of connexin32 expands cancer stem cell population in human HuH7 hepatoma cells by enhancing its self-renewal. | Q39731225 | ||
Aberrant expression and localization of connexin43 and connexin30 in a rat glioma cell line. | Q40040155 | ||
Connexin32‑mediated antitumor effects of suicide gene therapy against hepatocellular carcinoma: In vitro and in vivo anticancer activity | Q40875956 | ||
Non-junctional Cx32 mediates anti-apoptotic and pro-tumor effects via epidermal growth factor receptor in human cervical cancer cells. | Q41082556 | ||
c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. | Q41281287 | ||
Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases | Q41339821 | ||
Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction | Q41958034 | ||
Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver | Q44701266 | ||
Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication | Q46917709 | ||
EGFR family and Src family kinase interactions: mechanics matters? | Q47208117 | ||
Cx32 suppresses extrinsic apoptosis in human cervical cancer cells via the NF‑κB signalling pathway | Q47810107 | ||
Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha | Q24328857 | ||
EGFR Signaling in Liver Diseases | Q26771265 | ||
Hepatocellular carcinoma | Q29616359 | ||
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors | Q30009231 | ||
The gap junction protein connexin32 interacts with the Src homology 3/hook domain of discs large homolog 1. | Q30159462 | ||
c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function | Q30303639 | ||
Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers | Q30453944 | ||
Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice. | Q31443692 | ||
The role of connexin43-Src interaction in astrocytomas: A molecular puzzle | Q33360119 | ||
Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy | Q34783772 | ||
Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer | Q35010472 | ||
Role of connexin32 and beta-catenin in tumor promotion in mouse liver | Q35070532 | ||
Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways | Q35832932 | ||
Different gap junction-propagated effects on cisplatin transfer result in opposite responses to cisplatin in normal cells versus tumor cells | Q35895396 | ||
Molecular mechanisms regulating formation, trafficking and processing of annular gap junctions | Q36031604 | ||
Gap junctions and the propagation of cell survival and cell death signals | Q36134877 | ||
Pathological significance of intracytoplasmic connexin proteins: implication in tumor progression | Q36893654 | ||
Connexin-related signaling in cell death: to live or let die? | Q37386613 | ||
Gap junctions and cancer: communicating for 50 years | Q37613777 | ||
Epidermal Growth Factor Pathway Signaling in Drosophila Embryogenesis: Tools for Understanding Cancer. | Q37676070 | ||
Connexins: mechanisms regulating protein levels and intercellular communication | Q37707115 | ||
Gap junctions and connexins as therapeutic targets in cancer | Q37743527 | ||
Non-channel functions of connexins in cell growth and cell death | Q37896241 | ||
Molecular connexin partner remodeling orchestrates connexin traffic: from physiology to pathophysiology. | Q38007019 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageQuant | Q112270642 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
apoptotic process | Q14599311 | ||
P304 | page(s) | 145 | |
P577 | publication date | 2019-04-04 | |
P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
P1476 | title | Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma | |
P478 | volume | 38 |
Q97070246 | GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function | cites work | P2860 |
Search more.